Overview of vulvar pruritus through the life cycle

Clinical Obstetrics and Gynecology

Volumn 48, Issue 4, 2005, Pages 786-807

  Bohl, Tanja Gizela ^a,b  

^a Royal Women's Hospital ^*  (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; AMCINONIDE; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETAMETHASONE BENZOATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CONJUGATED ESTROGEN; CORTICOSTEROID; DESONIDE; DESOXIMETASONE; DIFLORASONE DIACETATE; DIPHENHYDRAMINE; DIPSONE; DOXEPIN; ESTRADIOL; FLORANE; FLUDROXYCORTIDE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; GRISEOFULVIN; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE VALERATE; HYDROXYZINE; IMIDAZOLE; IVERMECTIN; LINDANE; MAXIVATE; MOMETASONE FUROATE; PERMETHRIN; PIMECROLIMUS; PYRETHROID; SEROTONIN UPTAKE INHIBITOR; TACROLIMUS; TERBINAFINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC REACTION; CAREGIVER; CLINICAL FEATURE; CONTACT DERMATITIS; DISEASE CLASSIFICATION; DISEASE CONTROL; FOOD AND DRUG ADMINISTRATION; FOX FORDYCE DISEASE; HEALTH CARE PERSONNEL; HORMONE SUBSTITUTION; HUMAN; INFANCY; INTERTRIGO; LICHEN PLANUS; LIFE CYCLE; MENARCHE; MENOPAUSE; PATHOGENESIS; PRACTICE GUIDELINE; PREVENTION; PUBIC PEDICULOSIS; REVIEW; VAGINITIS; VULVA PRURITUS;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; ECTOPARASITIC INFESTATIONS; FEMALE; HUMANS; INFANT; LICHEN PLANUS; MENOPAUSE; PRURITUS VULVAE; PSORIASIS; VULVAR LICHEN SCLEROSUS;

EID: 29544439943     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000179636.64663.e6     Document Type: Review

References (60)

1. Wilhelm D, Elsner P, Maibach HI. Standardised trauma (tape stripping) in human vulvar and forearm skin. Effects on transepidermal water loss, capacitance and pH. Acta Derm Venereol. 1991;71:123-126.
2. Hafenreffer S. Nososdochium, in quo cutis, eique adaerentium partium, affectus omnes, singulari methodo, et cognoscendi e curandi fidelisime trandantur. Ulm: Kühenen; 1660:98-102.
3. Twycross R, Greaves MW, Handwerker H, et al. Itching: scratching more than the surface. Q J Med. 2003;96:7-26.
4. Yosipovitch G, Greaves M, Schmeltz M, et al. Experiments relating to itch, it's peripheral mechanisms, and central pathways. Clin Sci. 1938;3:377-386.
5. McMahon SB, Koltzenburg M. Itching for an explanation. Trends Neurosci. 1992;15:497-501.
6. Schmelz M. Itch - mediators and mechanisms. J Dermatol Sci. 2002;28:91-96.
7. Schmelz M, Handwerker HO. Pain and itch. In: Yosipovitch G, Greaves MW, Fleischer AB Jr, et al., eds. Itch. New York: Marcel Dekker, Inc; 2004.
8. Ikoma A, Rukwied R, Stander S, et al. Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol. 2003;139:1475-1478.
9. McGlone F, Rukweid R. Hitchcock D, et al. Histamine-induced discriminative and affective responses revealed by functional MRI. In: Yosipovitch G, Greaves MW, Fleischer AB Jr, et al., eds. Itch. New York: Marcel Dekker, Inc; 2004.
10. Darsow U, Drzezga A, Ring J. Central nervous system imaging of itch with PET. In: Yosipovitch G, Greaves MW, Fleischer AB Jr, et al., eds. Itch. New York: Marcel Dekker; 2004.
11. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol. 2001;185:545-550.
12. Paek SC, Merritt DF, Mallory SB. Pruritus vulvae in prepubertal children. J Am Acad Dermatol. 2001;5:795-802.
13. Bornstein J, Pascal B, Abramovich H. The common problem of vulvar pruritus. Obstet Gynecol Surv. 1993;48:111-118.
14. Goolamali SK. Pruritus vulvae. Clin Obstet Gynecol. 1981;8:227-240.
15. Pierce AM, Hart CA. Vulvovaginitis: causes and management. Arch Dis Child. 1992;67:509-512.
16. Pumpianski R, Sheskin J. Pruritus vulvae: a five year survey. Dermatologica. 1965;131:446-451.
17. Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologists perspective. Aust J Dermatol. 1996;37:12-18.
18. Kass-Wolff JH, Wilson EE. Pediatric gynecology: assessment strategies and common problems. Semin Reprod Med. 2003;21:329-338.
19. Marren P, Wojnarowska F. Dermatitis of the vulva. Semin Dermatol. 1996;15:36-41.
20. Ridley CM. Vulvar disease in the pediatric population. Semin Dermatol. 1996;15:29-35.
21. Crone AM, Stewart EJC, Wojnarowska F, et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol. 2000;14: 181-186.
22. Firooz A, Davoudi SM, Farahmand AM, et al. Validation of the diagnostic criteria for atopic dermatitis. Arch Dermatol. 1999; 35:514-516.
23. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol. 2001;44:803-806.
24. Nilwa Y, Terashima T, Sumi H. Topical application of immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol. 2003;149:960-967.
25. Wetzel S, Wollenberg A. Eczema molluscum in tacrolimus treated atopic dermatitis. Eur J Dermatol. 2004;14:73-74.
26. Siddiaiah N, Erickson Q, Miller G, et al. Tacrolimus induced tinea incognito. Cutis. 2004;73:234-238.
27. Goldstein AT, Marinoff SC, Chrisopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J Pediatr Adolesc Gynecol. 2004;17:35-37.
28. US Food and Drug Administration. FDA Public Health Advisory. Elidel (pimecrolimus) cream and Protopic (tacrolimus) ointment. Available at: http://www.fda.gov/cder/drug/advisory/elidel_protopic.htm. Accessed March 10, 2005.
29. Carli P, De Magnis A, Mannone F, et al. Vulvar Carcinoma Associated with Lichen Sclerosus. Experience at the Florence, Italy, Vulvar Clinic. J Reprod Med. 2003;5:313-318.
30. Gribetz C, Ling M, Lebwohl M, et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol. 2004;51:731-738.
31. Amichai B. Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus). J Eur Acad Dermatol Venereol. 2004;18:742-743.
32. Mogielnicki PA, Schwartzman JD, Elliot JA. Perineal group A streptococcal disease in a paediatric practice. Pediatrics. 2000;106:276-281.
33. Herbst R. Perineal streptococcal dermatitis/disease: recognition and management. Am J Clin Dermatol. 2003;4:555-560.
34. Brilliant LC. Perianal streptococcal dermatitis. Am Fam Physician. 2000;61:391-393, 397.
35. Margesson L. Contact dermatitis of the vulva. Dermatol Ther. 2004;17:20-27.
36. Kulozik M, Powell SM, Cherry G, et al. Contact sensitivity in a community based leg ulcer patients. Clin Exp Dermatol. 1985;13:82-84.
37. Patel DA, Gillespie B, Sobel JD, et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol. 2004;190:644-653.
38. Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal medications for gynecological symptoms. J Fam Pract. 1996;42:595-600.
39. Nyirjesy P, Sobel JD. Vulvovaginal candidiasis. Obstet Gynecol Clin North Am. 2003;30:671-684.
40. Sherertz EF. Clinical pearl: symptomatic dermatographism as a cause of genital pruritus. J Am Acad Dermalol. 1994;1040-1041.
41. Hancox JG, Sheridan SC, Feldman SR, et al. Seasonal variation of dermatologie disease in the USA; a study of office visits from 1990 to 1998. Int J Dermatol 2004;43:6-11.
42. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18:13.
43. Gupta A, Nikol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol. 2004;5:417-422.
44. Crespo EV, Delgado FV Malassezia species in skin diseases. Curr Opin Infect Dis. 2002;15:133-142.
45. Nakagawa H, Etoh T, et al. Tacrolimus has antifungal activity against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis. Clin Drug Invest. 1996;12:245-250.
46. Lynch P. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther. 2004;17:8-19.
47. Lewis FM. Vulval lichen planus. Br J Dermatol. 1998;138:569-575.
48. Kopera D, Soyer HP, Cerroni L. Vulvar syringoma causing pruritus and carcinophobia: treatment by argon laser. J Cutan Laser Ther. 1999;1:181-183.
49. Yu-Heuei H, Ya-Hui C, Tseng-Tong K, et al. Vulvar syringoma: a clinicopathological and immunohistologic study of 18 patients and results of treatment. J Am Acad Dermatol. 2003;48:735-739.
50. Herod JJ, Shaffi MI, Rollason TP, et al. Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva. Br J Obstet Gynaecol. 1996;103:xxi-xxii.
51. Kam-Cheong L, Su WPD, Muller SA. Multicentric cloacogenic carcinoma: report of a case with anogenital pruritus at presentation. J Am Acad Dermatol. 1990;23:1005-1008.
52. Arowojolu AO, Ladipo OA. Nonmenstrual adverse effects associated with subdermal contraceptive implants containing normegestrel and levonorgestrel. Afr J Med Med Sci. 2003;32:27-31.
53. Riordan J, Auerbach K. Breastfeeding and Human Lactation, 2nd ed. Sudbury, MA: Jones and Bartlett; 1998.
54. Wisniewski PM, Wilkinson EJ. Postpartum vaginal atrophy. Am J Obstet Gynecol. 1991;165:1249-1254.
55. Goestch MF. Postpartum dyspareunia. An unexplored problem. J Reprod Med. 2000;45:964.
56. Crandall C. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy. J Womens Health Gend Based Med. 2002;10:857-877.
57. Margesson LJ. Vulvovaginal dryness and itching. Skin Therapy Lett. 2001;6:10.
58. SOGC. The detection and management of vaginal atrophy. Int J Gynaecol Obstet. 2005;88:222-228.
59. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2003;4:CDOO1500.
60. Kelly R, Foster D, Woodruff D. Subcutaneous injection of triamcinolone acetonide in the treatment of chronic vulvar pruritus. Am J Obstet Gynecol. 1993;169:568-570.